Treatment of Early Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells
Status:
Active, not recruiting
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of autologous adipose
mesenchymal stem cells in the treatment of early knee arthritis. Investigator believes that
autologous adipose mesenchymal stem cells can relieve pain, improve knee function, promote
knee cartilage regeneration and improve life satisfaction of patients.